Patients with HCC recurrence had larger maximal tumour size and a greater tumour count, higher AFP concentration (Figure 1), poorer TNM stage (p = .001), and higher prevalence of vascular invasion (p < .001) than those with non-recurrence. This evidence concerns the gene AFP and hepatocellular carcinoma.